News
Japanese researchers trained an AI model to rate atopic dermatitis severity from patient-taken photos, showing 98% ...
TARRYTOWN, N.Y. and PARIS, June 07, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: REGN) and Sanofi today presented results from the DISCOVER Phase 4, single-arm, open-label trial assessing Dupixent ® (dupilumab) ...
Ivarmacitinib, also known as oral SHR0302, is not yet approved by the FDA, with trials currently exploring its utility in ...
The latest update atopic dermatitis guidelines include the new approval of lebrikizumab and the expanded use of baricitinib ...
New data from the Phase 3 INTEGUMENT-OLE long-term open label study show durable improvement in the signs and symptoms of atopic dermatitis (AD), including almost half of participants achieving no or ...
Other tips may include regularly moisturizing your skin and lowering your stress levels. Atopic dermatitis (AD), also known as eczema, is an inflammatory skin condition that may cause dry ...
Mayo Clinic reports that eyelid eczema or atopic dermatitis, is a chronic condition that stems from a problem with the skin’s protective barrier. If patients have this skin disease, the top layer of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results